DFCI/BCH-HITO quality improvement project for hematologic malignancies: implementation and validation of MRD by flow cytometry in pediatric acute leukemia treatment protocols

類似資料

• Utility of flow cytometry screening before MRD testing in multiple myeloma
  著者:: Vandana Panakkal, 等
  出版事項: (2023-04-01)
• Refinement of MRD Assessment in Hairy Cell Leukemia by Integrated Molecular and Flow Cytometry Analysis
  著者:: G. Urbani, 等
  出版事項: (2023-11-01)
• Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001
  著者:: Lynda M. Vrooman, 等
  出版事項: (2018-06-01)
• DP084 | FAILURE OF CONVENTIONAL MEASURABLE RESIDUAL DISEASE (MRD) ASSESSMENT BY FLOW CYTOMETRY IN ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING HIGH-DOSE CYTARABINE: REFINEMENT OF RELAPSE RISK BY THE APPLICATION OF AN ALTERNATIVE MRD DEFINITION MODEL
  著者:: L. Fasano, 等
  出版事項: (2025-09-01)
• ON CLOSED BCH-ALGEBRA WITH RESPECT TO AN ELEMENT OF A BCH-ALGEBRA
  著者:: Hussein Hadi Abbass
  出版事項: (2011-11-01)